Related Experiment Video
Updated: May 20, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical Trials.
Xiaoying Liang1, Paige A Taylor2, Heng Li3
1Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida.
Implementing proton therapy in multi-institutional clinical trials requires clear technical guidance to ensure consistent treatment and reliable outcome data. This guideline addresses challenges for harmonized conduct and robust data collection in proton therapy research.
Area of Science:
- Medical Physics
- Radiation Oncology
- Clinical Trials
Background:
- Proton therapy integration into clinical trials is growing.
- Evolving technology and unique properties present challenges in protocol design and data interpretation.
- Standardized approaches are needed for multi-institutional proton therapy trials.
Purpose of the Study:
- To outline key technical considerations for implementing proton therapy in multi-institutional clinical trials.
- To provide guidance for harmonized trial conduct and reliable data collection.
- To address challenges in protocol design, treatment consistency, and outcome assessment for proton therapy research.
Main Methods:
- Review of NRG Oncology protocols involving proton therapy.
- Examination of technical challenges: setup/range uncertainties, motion effects, anatomical changes, RBE variability, plan evaluation.
- Development of recommendations based on clinical practice and multi-institutional trial experience.
Main Results:
- Variability in treatment consistency and outcome interpretation identified in multi-institutional proton therapy trials.
- Inconsistencies found in proton therapy stratification, randomization, technical requirements, and reporting practices.
- Recommendations provided to enhance protocol clarity, robustness assessment, and standardize data collection for cross-institutional comparison.
Conclusions:
- Clear technical guidance is essential for data quality and outcome interpretability as proton therapy use expands in cooperative group trials.
- A technical framework is provided to harmonize proton therapy implementation in multi-institutional trials.
- Considerations for emerging proton therapy technologies are discussed to support future research.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020